Upgrade to SI Premium - Free Trial

Brainstorm Cell Therapeutics (BCLI)

1.17 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 3 BRAINSTORM CELL THERAPEU For: May 25 Filed by: Pitts Peter Joe June 3, 2026 5:38 PM - SEC Filing Form EFFECT BRAINSTORM CELL THERAPEU June 3, 2026 6:05 AM - SEC Filing BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine June 2, 2026 9:00 AM - PR NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Lebovits Chaim May 29, 2026 5:03 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Yablonka Uri May 29, 2026 5:02 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Patlis Alla May 29, 2026 5:02 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: FRENKEL JACOB A May 29, 2026 5:01 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: ARBEL IRIT May 29, 2026 5:01 PM - SEC Filing Form 8-K BRAINSTORM CELL THERAPEU For: May 25 May 28, 2026 4:50 PM - SEC Filing BrainStorm Cell Therapeutics adds former FDA associate commissioner to board May 28, 2026 7:45 AM - StreetInsider BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors May 28, 2026 7:45 AM - PR NewsWire Form S-8 BRAINSTORM CELL THERAPEU May 21, 2026 6:01 AM - SEC Filing Form S-1 BRAINSTORM CELL THERAPEU May 21, 2026 6:01 AM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Bairu Menghisteab May 20, 2026 6:07 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Polverino Anthony J. May 20, 2026 6:06 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: HARTOUNIAN HARTOUN May 20, 2026 6:05 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Lindborg Stacy May 20, 2026 6:04 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Naor Nir May 20, 2026 6:02 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Feb 26 Filed by: Dagher Ibrahim B. May 20, 2026 6:01 PM - SEC Filing BrainStorm Cell Therapeutics raises $400,000 in private placement May 19, 2026 8:04 AM - StreetInsider BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market May 19, 2026 8:00 AM - PR NewsWire Form 8-K BRAINSTORM CELL THERAPEU For: May 15 May 15, 2026 5:01 PM - SEC Filing Form 10-Q BRAINSTORM CELL THERAPEU For: Mar 31 May 15, 2026 4:38 PM - SEC Filing BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update May 15, 2026 4:05 PM - PR NewsWire Form 10-K BRAINSTORM CELL THERAPEU For: Dec 31 March 31, 2026 5:27 PM - SEC Filing Form 8-K BRAINSTORM CELL THERAPEU For: Mar 31 March 31, 2026 4:19 PM - SEC Filing BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update March 31, 2026 4:01 PM - PR NewsWire Full Article List